United Therapeutics Stock
United Therapeutics Stock
United Therapeutics shows a slight decrease today, losing -€1.000 (-0.220%) compared to yesterday.
The stock is one of the favorites of our community with 29 Buy predictions and 1 Sell predictions.
As a result the target price of 541 € shows a positive potential of 21.87% compared to the current price of 443.9 € for United Therapeutics.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for United Therapeutics stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of United Therapeutics in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | -0.220% | -1.202% | -7.386% | 71.854% | 3.885% | 104.280% | 153.657% |
| Ionis Pharmaceuticals Inc. | 1.690% | 4.583% | -3.842% | 38.314% | -27.810% | 35.338% | 46.404% |
| Ligand Pharmaceuticals | 1.560% | -4.580% | -9.420% | 96.850% | 50.602% | 296.825% | 166.923% |
| Novocure Ltd | 1.630% | 8.472% | 7.105% | 62.731% | 34.980% | -46.410% | -87.428% |
Comments
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $704.00 to $677.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by JPMorgan Chase & Co. from $685.00 to $687.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat